Deutsche Bank
NYMX

Deutsche Bank’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Deutsche Bank’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-30,306
Closed -$67K – 4878
2021
Q1 		$67K Sell
30,306
-2,568
-8% -$6.77K ﹤0.01% 4159
2020
Q4 		$82K Buy
32,874
+9,663
+42% +$21.4K ﹤0.01% 3953
2020
Q3 		$57K Buy
23,211
+1,894
+9% +$5.51K ﹤0.01% 3829
2020
Q2 		$76K Sell
21,317
-8,683
-29% -$27.5K ﹤0.01% 3599
2020
Q1 		$70K Buy
30,000
+16,135
+116% +$45.3K ﹤0.01% 3401
2019
Q4 		$30K Buy
13,865
+6,039
+77% +$11.9K ﹤0.01% 4167
2019
Q3 		$14K Sell
7,826
-14,664
-65% -$25.6K ﹤0.01% 4441
2019
Q2 		$31K Sell
22,490
-16,828
-43% -$29.4K ﹤0.01% 4692
2019
Q1 		$76K Sell
39,318
-2,444
-6% -$5.18K ﹤0.01% 4410
2018
Q4 		$53K Sell
41,762
-31,370
-43% -$57.4K ﹤0.01% 4463
2018
Q3 		$180K Buy
73,132
+12,280
+20% +$36.3K ﹤0.01% 4283
2018
Q2 		$205K Buy
60,852
+19,044
+46% +$73.2K ﹤0.01% 4275
2018
Q1 		$176K Sell
41,808
-29,689
-42% -$103K ﹤0.01% 4255
2017
Q4 		$234K Buy
71,497
+43,673
+157% +$159K ﹤0.01% 3958
2017
Q3 		$105K Sell
27,824
-46,452
-63% -$176K ﹤0.01% 4151
2017
Q2 		$325K Buy
+74,276
New +$305K ﹤0.01% 3680
2016
Q3 		– Sell
-7,314
Closed -$24K – 5285
2016
Q2 		$24K Buy
7,314
+5,265
+257% +$12.9K ﹤0.01% 4707
2016
Q1 		$4K Buy
2,049
+1,957
+2,127% +$4.63K ﹤0.01% 4988
2015
Q4 		$0 Buy
+92
New +$309 ﹤0.01% 5461
2014
Q2 		– Sell
-800
Closed -$4K – 6124
2014
Q1 		$4K Sell
800
-2,597
-76% -$15.1K ﹤0.01% 5244
2013
Q4 		$20K Sell
3,397
-46,025
-93% -$314K ﹤0.01% 4732
2013
Q3 		$326K Buy
49,422
+22,822
+86% +$149K ﹤0.01% 3805
2013
Q2 		$134K Buy
+26,600
New +$135K ﹤0.01% 4054

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Deutsche Bank's NYMX Position: Q2 2021 in Review

Deutsche Bank sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2021, closing a stake of 30,306 shares — an estimated $67K sold.

Deutsche Bank first reported a position in NYMX in Q2 2013 and held it in 23 quarters. The position peaked at $326K in Q3 2013. 51 funds tracked by Wall St. Rank hold NYMX as of Q2 2021.

  • Deutsche Bank reported no remaining Nymox Pharmaceutical Corp position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 30,306 Nymox Pharmaceutical Corp shares in Q2 2021, an estimated $67K.
  • Deutsche Bank first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 23 quarters.
  • Deutsche Bank's Nymox Pharmaceutical Corp position peaked at $326K in Q3 2013.
  • 51 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.